Association Between Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed

Clinical trial NCT03537833 · COMPLETED

Trial details

NCT number: NCT03537833
Sponsor: CHU de Reims
Status: COMPLETED
Study type: OBSERVATIONAL

Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy

Start date: 2018-05-02
Primary completion: 2021-02-18
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.